December 11, 2024 18:37 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
No alliance with Congress in Delhi polls: AAP chief Arvind Kejriwal | Bengaluru techie's suicide: Atul Subhash's wife and her family booked | Bengaluru techie's suicide: Atul Subhash's wife and her family booked | INDIA bloc to knock on Supreme Court's doors over alleged EVM manipulation during Maharashtra polls | 'Babri Masjid should be rebuilt in Bengal's Murshidabad': TMC MLA Humayun Kabir sparks row | Rajnath Singh calls on Russian Prez Vladimir Putin in Moscow, discusses bilateral defence cooperation | Police to investigate conspiracy angle in Mumbai bus accident that killed 7 | Mamata Banerjee should lead INDIA bloc: Lalu Prasad Yadav | Opposition moves no-confidence motion against VP Jagdeep Dhankar in RS | Mumbai bus accident: Toll rises to seven, 42 injured
Sanofi collaborates with Dr. Reddy’s Labs to promote and distribute its vaccine brands in India

Sanofi collaborates with Dr. Reddy’s Labs to promote and distribute its vaccine brands in India

Mar 28, 2024, at 05:26 am

New Delhi: Hyderabad-based pharmaceutical major Dr. Reddy’s Laboratories Limited (DRL) on Wednesday announced an exclusive partnership with Sanofi Healthcare India Private Limited to promote and distribute Sanofi’s vaccine brands across the country.

Dr Reddy's Q2 Result: Consolidated net profit jumps 30 pc

Dr Reddy's Q2 Result: Consolidated net profit jumps 30 pc

Oct 30, 2021, at 07:00 am

Mumbai/IBNS: Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY) Friday declared a year-on-year (YoY) rise in consolidated net profit at Rs 992 crore, up 30 per cent.

Dr Reddy's Labs launches Trientine Hydrochloride Capsules in US Market

Dr Reddy's Labs launches Trientine Hydrochloride Capsules in US Market

Feb 07, 2020, at 02:39 pm

Mumbai/UNI Pharma Major Dr Reddy's Laboratories on Friday announced the US launch of Trientine Hydrochloride Capsules a therapeutically equivalent generic version of Syprine (trientine hydrochloride) Capsules, approved by the US Food and Drug Administration (USFDA).